pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-7515 |
Genomic Coordinates | chr2: 6650373 - 6650439 |
Description | Homo sapiens miR-7515 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-7515 | |||||||||||||||||||||||||||
Sequence | 46| AGAAGGGAAGAUGGUGAC |63 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MAT2A | ||||||||||||||||||||
Synonyms | MATA2, MATII, SAMS2 | ||||||||||||||||||||
Description | methionine adenosyltransferase 2A | ||||||||||||||||||||
Transcript | NM_005911 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MAT2A | |||||||||||||||||||||
3'UTR of MAT2A (miRNA target sites are highlighted) |
>MAT2A|NM_005911|3'UTR 1 AAGTGTTAGCCTTTTTTCCCCAGACTTGTTGGCGTAGGCTACAGAGAAGCCTTCAAGCTCTGAGGGAAAGGGCCCTCCTT 81 CCTAAATTTTCCTGTCCTCTTTCAGCTCCTGACCAGTTGCAGTCACTCTAGTCAATGACATGAATTTTAGCTTTTGTGGG 161 GGACTGTAAGTTGGGCTTGCTATTCTGTCCCTAGGTGTTTTGTTCACCATTATAATGAATTTAGTGAGCATAGGTGATCC 241 ATGTAACTGCCTAGAAACAACACTGTAGTAAATAATGCTTTGAAATTGAACCTTTGTGCCCTATCACCCAACGCTCCAAA 321 GTCATAATTGCATTGACTTTCCCCACCAGATGCTGAAAATGTCCTTGTGATGTGCACGTAAAGTACTTGTAGTTCCACTT 401 ATAGCCTCTGTCTGGCAATGCCACAGCCCTGTCAGCATGAATTTGTAATGTCTTGAGCTCTATTATGAATGTGAAGCCTT 481 CCCCTTATCCTCCCTGTAACTTGATCCATTTCTAATTATGTAGCTCTTTGTCAGGGAGTGTTCCCTATCCAATCAATCTT 561 GCATGTAACGCAAGTTCCCAGTTGGAGCTCCAGCCTGACATCAAAAAAGGCAGTTACCATTAAACCATCTCCCTGGTGCT 641 TATGCTCTTAATTGCCACCTCTAACAGCACCAAATCAAAATCTCTCCACTTTCAGCTGTCTTTTGGAGGACGTACGTAAT 721 AAGGTTTTAATTTAGTAAACCAATCCTATGCATGGTTTCAGCACTAGCCAAACCTCACCAACTCCTAGTTCTAGAAAAAC 801 AGGCACTTGGCAGCCTTGTGATGTCATACAGAGAAGTCACAGGGCAGTACCTGAGGGTCTGTAGGTTGCACACTTTGGTA 881 CCAGATAACTTTTTTTTTTCTTTATAAGAAAGCCTGAGTACTCCACACTGCACAATAACTCCTCCCAGGGTTTTAACTTT 961 GTTTTATTTTCAAAACCAGGTCCAATGAGCTTTCTGAACAGCTGGTGTAGCTACAGAGAAACCAGCTTCCTTCAGAGAGC 1041 AGTGCTTTTGGCGGGGAGGAGGAAATCCCTTCATACTTGAACGTTTTCTAATTGCTTATTTATTGTATTCTGGGGTATGG 1121 CGTAAGTACAGAGAAGCCATCACCTCAGATGGCAGCTTTTAAAAGATTTTTTTTTTTTCTCTCAACACCATGATTCCTTT 1201 AACAACATGTTTCCAGCATTCCCAGGTAGGCCAAGGTGTCCTACAGAAAAACCTTGGGTTAGACCTACAGGGGGTCTGGC 1281 TGGTGTTAACAGAAGGGAGGGCAGAGCTGGTGCGGCTGGCCATGGAGAAAGCTGACTTGGCTGGTGTGGTACAGAGAAGC 1361 CAGCTTGTTTACATGCTTATTCCATGACTGCTTGCCCTAAGCAGAAAGTGCCTTTCAGGATCTATTTTTGGAGGTTTATT 1441 ACGTATGTCTGGTTCTCAATTCCAACAGTTTAATGAAGATCTAAATAAAATGCTAGGTTCTACCTTAAAAAAAAAAAAAA 1521 AAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545213. RNA binding protein: AGO2. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 4144.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM714642. RNA binding protein: AGO2. Condition:completeT1
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 4144.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 4144.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 5 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM714642 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000306434.3 | 3UTR | GGAGGAGGAAAUCCCUUCAUACUUGAACGUUUUCUAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000306434.3 | 3UTR | AAAUCCCUUCAUACUUGAACG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545213 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000306434.3 | 3UTR | AAAUCCCUUCAUACUUGAACG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000306434.3 | 3UTR | AAAUCCCUUCAUACUUGAACG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000306434.3 | 3UTR | AAAUCCCUUCAUACUUGAACG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000306434.3 | 3UTR | AGGAGGAAAUCCCUUCAUACUUGAACGUUUUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000306434.3 | 3UTR | AGGAAAUCCCUUCAUACUUGAACGUUUUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000306434.3 | 3UTR | AAAUCCCUUCAUACUUGAACGUUUUCUAAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000306434.3 | 3UTR | AAAUCCCUUCAUACUUGAACG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM1065669 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000306434.3 | 3UTR | AAAUCCCUUCAUACUUGAACG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000306434.3 | 3UTR | AAAUCCCUUCAUACUUGAACG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000306434.3 | 3UTR | AAAUCCCUUCAUACUUGAACG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
116 hsa-miR-7515 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT063460 | SKI | SKI proto-oncogene | 2 | 4 | ||||||||
MIRT089615 | MAT2A | methionine adenosyltransferase 2A | 2 | 10 | ||||||||
MIRT100238 | PRR3 | proline rich 3 | 2 | 4 | ||||||||
MIRT159239 | NRBP1 | nuclear receptor binding protein 1 | 2 | 2 | ||||||||
MIRT183526 | BTG2 | BTG anti-proliferation factor 2 | 2 | 2 | ||||||||
MIRT266866 | SLC25A44 | solute carrier family 25 member 44 | 2 | 2 | ||||||||
MIRT304116 | CNNM4 | cyclin and CBS domain divalent metal cation transport mediator 4 | 2 | 4 | ||||||||
MIRT331077 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT350659 | PDIA6 | protein disulfide isomerase family A member 6 | 2 | 2 | ||||||||
MIRT438442 | MET | MET proto-oncogene, receptor tyrosine kinase | 3 | 1 | ||||||||
MIRT443555 | ZFP3 | ZFP3 zinc finger protein | 2 | 2 | ||||||||
MIRT447969 | MSH6 | mutS homolog 6 | 2 | 2 | ||||||||
MIRT448635 | ONECUT1 | one cut homeobox 1 | 2 | 2 | ||||||||
MIRT451778 | USP36 | ubiquitin specific peptidase 36 | 2 | 2 | ||||||||
MIRT452615 | REPIN1 | replication initiator 1 | 2 | 2 | ||||||||
MIRT453433 | GLG1 | golgi glycoprotein 1 | 2 | 2 | ||||||||
MIRT454015 | ALKBH5 | alkB homolog 5, RNA demethylase | 2 | 2 | ||||||||
MIRT454961 | TPM2 | tropomyosin 2 | 2 | 2 | ||||||||
MIRT455364 | KDM5C | lysine demethylase 5C | 2 | 2 | ||||||||
MIRT455434 | ID3 | inhibitor of DNA binding 3, HLH protein | 2 | 2 | ||||||||
MIRT455456 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | 2 | 2 | ||||||||
MIRT455595 | TAF12 | TATA-box binding protein associated factor 12 | 2 | 2 | ||||||||
MIRT455689 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT455949 | CYP4A22 | cytochrome P450 family 4 subfamily A member 22 | 2 | 2 | ||||||||
MIRT456135 | SAMD10 | sterile alpha motif domain containing 10 | 2 | 2 | ||||||||
MIRT456821 | PIGP | phosphatidylinositol glycan anchor biosynthesis class P | 2 | 2 | ||||||||
MIRT457441 | NOL10 | nucleolar protein 10 | 2 | 2 | ||||||||
MIRT458048 | TSEN54 | tRNA splicing endonuclease subunit 54 | 2 | 2 | ||||||||
MIRT458237 | NXPH3 | neurexophilin 3 | 2 | 2 | ||||||||
MIRT458671 | GPR35 | G protein-coupled receptor 35 | 2 | 2 | ||||||||
MIRT458741 | CES2 | carboxylesterase 2 | 2 | 2 | ||||||||
MIRT459102 | CYP4A11 | cytochrome P450 family 4 subfamily A member 11 | 2 | 2 | ||||||||
MIRT459676 | VPS37C | VPS37C, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT459776 | IDH3A | isocitrate dehydrogenase 3 (NAD(+)) alpha | 2 | 2 | ||||||||
MIRT461975 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 2 | 2 | ||||||||
MIRT462267 | TPI1 | triosephosphate isomerase 1 | 2 | 2 | ||||||||
MIRT463296 | ZFP91 | ZFP91 zinc finger protein | 2 | 2 | ||||||||
MIRT463446 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT464379 | URM1 | ubiquitin related modifier 1 | 2 | 2 | ||||||||
MIRT465552 | TOB2 | transducer of ERBB2, 2 | 2 | 2 | ||||||||
MIRT467359 | SP2 | Sp2 transcription factor | 2 | 2 | ||||||||
MIRT467638 | SLC7A5 | solute carrier family 7 member 5 | 2 | 2 | ||||||||
MIRT467795 | SLC2A14 | solute carrier family 2 member 14 | 2 | 2 | ||||||||
MIRT468466 | SET | SET nuclear proto-oncogene | 2 | 4 | ||||||||
MIRT468725 | SDC4 | syndecan 4 | 2 | 2 | ||||||||
MIRT468784 | SCAMP5 | secretory carrier membrane protein 5 | 2 | 2 | ||||||||
MIRT469154 | RNF121 | ring finger protein 121 | 2 | 2 | ||||||||
MIRT473436 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT473636 | MARK2 | microtubule affinity regulating kinase 2 | 2 | 2 | ||||||||
MIRT474242 | LCLAT1 | lysocardiolipin acyltransferase 1 | 2 | 2 | ||||||||
MIRT474654 | KLF13 | Kruppel like factor 13 | 2 | 2 | ||||||||
MIRT475384 | ICOSLG | inducible T-cell costimulator ligand | 2 | 2 | ||||||||
MIRT475400 | ICMT | isoprenylcysteine carboxyl methyltransferase | 2 | 4 | ||||||||
MIRT476369 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 2 | ||||||||
MIRT478017 | DNAJC8 | DnaJ heat shock protein family (Hsp40) member C8 | 2 | 2 | ||||||||
MIRT478459 | DAB2 | DAB2, clathrin adaptor protein | 2 | 2 | ||||||||
MIRT478791 | CRTC2 | CREB regulated transcription coactivator 2 | 2 | 2 | ||||||||
MIRT478952 | COX15 | COX15, cytochrome c oxidase assembly homolog | 2 | 2 | ||||||||
MIRT480412 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 2 | ||||||||
MIRT481455 | ARRB2 | arrestin beta 2 | 2 | 2 | ||||||||
MIRT481556 | ARL10 | ADP ribosylation factor like GTPase 10 | 2 | 2 | ||||||||
MIRT481740 | APH1A | aph-1 homolog A, gamma-secretase subunit | 2 | 2 | ||||||||
MIRT483592 | SLC26A9 | solute carrier family 26 member 9 | 2 | 2 | ||||||||
MIRT484423 | SNX19 | sorting nexin 19 | 2 | 2 | ||||||||
MIRT484727 | HOXB8 | homeobox B8 | 2 | 6 | ||||||||
MIRT487419 | CACNB1 | calcium voltage-gated channel auxiliary subunit beta 1 | 2 | 2 | ||||||||
MIRT487622 | C20orf96 | chromosome 20 open reading frame 96 | 2 | 2 | ||||||||
MIRT488048 | PABPC1L2B | poly(A) binding protein cytoplasmic 1 like 2B | 2 | 2 | ||||||||
MIRT488064 | PABPC1L2A | poly(A) binding protein cytoplasmic 1 like 2A | 2 | 2 | ||||||||
MIRT488587 | ST7L | suppression of tumorigenicity 7 like | 2 | 2 | ||||||||
MIRT488696 | NAT9 | N-acetyltransferase 9 (putative) | 2 | 2 | ||||||||
MIRT489175 | ANKRD45 | ankyrin repeat domain 45 | 2 | 4 | ||||||||
MIRT490435 | MYL9 | myosin light chain 9 | 2 | 2 | ||||||||
MIRT490452 | GLUD1 | glutamate dehydrogenase 1 | 2 | 2 | ||||||||
MIRT490704 | FSTL4 | follistatin like 4 | 2 | 2 | ||||||||
MIRT491038 | ALPK3 | alpha kinase 3 | 2 | 2 | ||||||||
MIRT491249 | HCN2 | hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 | 2 | 2 | ||||||||
MIRT491632 | SEMA4G | semaphorin 4G | 2 | 2 | ||||||||
MIRT492491 | RAPGEF1 | Rap guanine nucleotide exchange factor 1 | 2 | 2 | ||||||||
MIRT492506 | RANBP10 | RAN binding protein 10 | 2 | 4 | ||||||||
MIRT493917 | FAM127B | retrotransposon Gag like 8A | 2 | 4 | ||||||||
MIRT494012 | DUSP9 | dual specificity phosphatase 9 | 2 | 2 | ||||||||
MIRT499188 | RBPJL | recombination signal binding protein for immunoglobulin kappa J region like | 2 | 2 | ||||||||
MIRT499813 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT501837 | NCOA2 | nuclear receptor coactivator 2 | 2 | 2 | ||||||||
MIRT504067 | KCTD12 | potassium channel tetramerization domain containing 12 | 2 | 4 | ||||||||
MIRT505313 | TOR1AIP2 | torsin 1A interacting protein 2 | 2 | 2 | ||||||||
MIRT511829 | H2AFX | H2A histone family member X | 2 | 4 | ||||||||
MIRT515497 | GTF2F1 | general transcription factor IIF subunit 1 | 2 | 2 | ||||||||
MIRT518629 | NONO | non-POU domain containing octamer binding | 2 | 2 | ||||||||
MIRT519774 | ZNF354B | zinc finger protein 354B | 2 | 8 | ||||||||
MIRT521806 | POM121C | POM121 transmembrane nucleoporin C | 2 | 2 | ||||||||
MIRT522621 | MAP7D1 | MAP7 domain containing 1 | 2 | 4 | ||||||||
MIRT532803 | CLDN11 | claudin 11 | 2 | 2 | ||||||||
MIRT533783 | TMEM119 | transmembrane protein 119 | 2 | 2 | ||||||||
MIRT536433 | KMT2B | lysine methyltransferase 2B | 2 | 6 | ||||||||
MIRT538700 | CASP16 | caspase 16, pseudogene | 2 | 4 | ||||||||
MIRT544603 | DCAF5 | DDB1 and CUL4 associated factor 5 | 2 | 2 | ||||||||
MIRT556730 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT560587 | LCE1B | late cornified envelope 1B | 2 | 2 | ||||||||
MIRT560617 | ANKRD36 | ankyrin repeat domain 36 | 2 | 2 | ||||||||
MIRT564348 | AKR1B10 | aldo-keto reductase family 1 member B10 | 2 | 2 | ||||||||
MIRT568925 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | 2 | 2 | ||||||||
MIRT570946 | CPE | carboxypeptidase E | 2 | 2 | ||||||||
MIRT571235 | SCAMP4 | secretory carrier membrane protein 4 | 2 | 2 | ||||||||
MIRT573805 | FRMPD4 | FERM and PDZ domain containing 4 | 2 | 2 | ||||||||
MIRT574149 | MARVELD1 | MARVEL domain containing 1 | 2 | 2 | ||||||||
MIRT575772 | Tnfrsf10b | tumor necrosis factor receptor superfamily, member 10b | 2 | 2 | ||||||||
MIRT576154 | Hmox1 | heme oxygenase 1 | 2 | 2 | ||||||||
MIRT611312 | CA8 | carbonic anhydrase 8 | 2 | 4 | ||||||||
MIRT615891 | MT1A | metallothionein 1A | 2 | 2 | ||||||||
MIRT669589 | AK2 | adenylate kinase 2 | 2 | 2 | ||||||||
MIRT687186 | PRKAR1A | protein kinase cAMP-dependent type I regulatory subunit alpha | 2 | 2 | ||||||||
MIRT692711 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 | ||||||||
MIRT701346 | NR4A3 | nuclear receptor subfamily 4 group A member 3 | 2 | 2 | ||||||||
MIRT701997 | MIER3 | MIER family member 3 | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|